Mosanna Therapeutics
PrivateLast Round
Series A
Jun 9, 2025
Total Funding Raised
$80M
Momentum Score
25 /100
Company Overview
Mosanna Therapeutics is a clinical-stage biotechnology company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mosanna Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Mosanna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2025 | ||||
| Seed | Jul 13, 2022 |
Mosanna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A |
| Forty51 Ventures | Series A, Seed |
| Norwest Venture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Supermoon Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 140% MoM, reaching 2.1K.
- Jun 20, 2025
David Weber appointed President and CEO.
Mosanna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mosanna Therapeutics's valuation, stock price, and market status.
